UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 16, 2026
VIVOSIM LABS, INC.
(Exact name of registrant as specified in its charter)
Commission File Number: 001-35996
Delaware 27-1488943
(State... (continue reading...)
http://archive.fast-edgar.com/20260717/AFB4O22C8Z22V9ZA22ZA2ZZZNDQWZ2U2Z28G
Filed on: July 17, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2026
Commission File Number 001-42672
ALLIED GOLD CORPORATION
(Exact name of Registrant as specified in its charter)
N/A
(Translation of Registrant’s name into English)
Royal Bank... (continue reading...)
More SEC Filings
View Older Stories-
Form 4 NGL Energy Partners LP For: Jul 15 Filed by: REINERS DEREK S
-
Form 497 Voya PARTNERS INC
-
Form 6-K Central North Airport For: Jul 17
-
Form N-PX Syntegra Private Wealth For: Jun 30
-
Form D Aliya Growth Fund LLC -
-
Form 4 NGL Energy Partners LP For: Jul 15 Filed by: GUDERIAN BRYAN K
-
Form D/A AVCF7 LP
-
Form 8-K OPEN TEXT CORP For: Jul 17
-
Form 4 NGL Energy Partners LP For: Jul 15 Filed by: Cooper Bradley P
-
Form N-PX Once Capital Management, For: Jun 30
-
Form 8-K MEDIFAST INC For: Jul 17
-
Form 485BXT Investment Managers Seri
-
Form 4 Gain Therapeutics, Inc. For: Jul 15 Filed by: GOLDSTEIN DOV A MD
-
Form 485BXT Investment Managers Seri
-
Form 4 NGL Energy Partners LP For: Jul 15 Filed by: COLLINGSWORTH JAMES M
-
Form 4 Gain Therapeutics, Inc. For: Jul 15 Filed by: Nicaise Claude
-
Form 485BXT Investment Managers Seri
-
Form 4 Gain Therapeutics, Inc. For: Jul 15 Filed by: Islam Khalid
-
Form 4 Gain Therapeutics, Inc. For: Jul 15 Filed by: Melincoff Gwen A
-
Form 8-K Sadot Group Inc. For: Jul 14
-
Form 4 Gain Therapeutics, Inc. For: Jul 15 Filed by: Riley Jeffrey Scott
-
Form 6-K QTREX Quantum Ltd. For: Jul 17
-
Form 8-K Columbia Financial, Inc. For: Jul 16
-
Form 8-K Canton Strategic Holding For: Jul 13
-
Form 4 Gain Therapeutics, Inc. For: Jul 15 Filed by: HASLER HANS PETER
-
Form 4 NGL Energy Partners LP For: Jul 15 Filed by: Coady Shawn W
-
Form FWP GOLDMAN SACHS GROUP INC Filed by: GOLDMAN SACHS GROUP INC
-
Form FWP GS Finance Corp. Filed by: GS Finance Corp.
-
Form 4 JABIL INC For: Jul 15 Filed by: Schick Gary K.
-
Form 497 COLUMBIA ACORN TRUST
-
Form 6-K Guardian Metal Resources For: Jul 17
-
Form 425 ENDRA Life Sciences Inc. Filed by: ASP Isotopes Inc.
-
Form 425 ENDRA Life Sciences Inc. Filed by: ENDRA Life Sciences Inc.
-
Form 8-K CROSS COUNTRY HEALTHCARE For: Jul 16
-
Form 8-K Kimbell Royalty Partners For: Jul 16
-
Form F-1/A Genneia S.A.
-
Form D Arrhen, Inc.
-
Form D Goodword Jan 2026 a Seri
-
Form D ANTR-6, a series of ALEX
-
Form D/A ITE Air Fund L.P.
-
Form 8-K INFINITY NATURAL RESOURC For: Jul 17
-
Form D/A Cogniate US Pre-Seed
-
Form 424B3 BANK OF NOVA SCOTIA
-
Form 3 JOHN WILEY & SONS, INC. For: Jul 09 Filed by: Scognamiglio Frank
-
Form 6-K Elevra Lithium Ltd For: Jul 17
-
Form 8-K Polaryx Therapeutics, For: Jul 16
-
Form 8-K Cocrystal Pharma, Inc. For: Jul 14
-
Form D/A BP 2026 AUTO a Series
-
Form D PARKWAY BANCORP INC/IL
-
Form 4 James Hardie Industries For: Jul 15 Filed by: Hill David Lawrence

